← Russell 3000 cross-section

TKNO Alpha Teknova, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-06, not restated
Healthcare

Scale

Market cap
$398m
Revenue TTM
$44m
Net income TTM
$-17m
Free cash flow
$-7m
Composite score
40.2
Sector rank
#2513

Valuation

P / E
EV / EBITDA
EV / sales
9.0
FCF yield
-1.85%
Earnings yield vs 10-yr
-8.95pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-38.4%
EBITDA margin
-21.7%
ROE
-26.8%
ROIC
-27.1%
Revenue growth
12.3%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

We generated revenue of $12.2 million during the three months ended June 30, 2026, which represented an increase of $1.9 million compared to revenue of $10.3 million during the three months ended June 30, 2025. For the three months ended June 30, 2026 and 2025, only 4.3% and 5.0%, respectively, of our revenue was generated from customers located outside of the United States. For the six months ended June 30, 2026 and 2025, only 4.5% and 5.1%, respectively, of our revenue was generated from customers located outside of the United States. We primarily generate sales through direct channels and a small salesforce, supported by an established network of distributors. …Alpha Teknova, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-06

Read the full passage →